HUMAW (STOCKS)
Humacyte, Inc. Warrant
$0.099900
+0.000000 (+0.00%)
Prev close: $0.099900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Laura E. Niklason, MD, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 220
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.04M |
| Benefits Costs and Expenses | $42.87M |
| Cost Of Revenue | $9.70M |
| Costs And Expenses | $110.18M |
| Gross Profit | -$7.66M |
| Nonoperating Income/Loss | $67.30M |
| Operating Expenses | $100.47M |
| Research and Development | $69.30M |
| Other Operating Expenses | $31.17M |
| Operating Income/Loss | -$108.14M |
| Income/Loss From Continuing Operations After Tax | -$40.83M |
| Income/Loss From Continuing Operations Before Tax | -$40.83M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$40.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$40.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$40.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.26 |
| Diluted Earnings Per Share | -$0.26 |
| Basic Average Shares | 158,160,468 |
| Diluted Average Shares | 158,160,468 |
| Assets | $116.37M |
| Current Assets | $67.80M |
| Inventory | $13.59M |
| Other Current Assets | $54.21M |
| Noncurrent Assets | $48.57M |
| Fixed Assets | $18.54M |
| Other Non-current Assets | $30.03M |
| Liabilities | $113.26M |
| Current Liabilities | $18.37M |
| Accounts Payable | $5.40M |
| Wages | $6.63M |
| Other Current Liabilities | $6.34M |
| Noncurrent Liabilities | $94.89M |
| Long-term Debt | $35.44M |
| Other Non-current Liabilities | $59.44M |
| Equity | $3.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.11M |
| Liabilities And Equity | $116.37M |
| Net Cash Flow From Operating Activities | -$105.04M |
| Net Cash Flow From Operating Activities, Continuing | -$105.04M |
| Net Cash Flow From Investing Activities | -$884.00K |
| Net Cash Flow From Investing Activities, Continuing | -$884.00K |
| Net Cash Flow From Financing Activities | $61.49M |
| Net Cash Flow From Financing Activities, Continuing | $61.49M |
| Net Cash Flow | -$44.44M |
| Net Cash Flow, Continuing | -$44.44M |
| Comprehensive Income/Loss | -$40.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.83M |
| Other Comprehensive Income/Loss | $0.00 |